Tilray reported financial performance for Q2-2026 with international sales driving growth. Tilray remains undervalued after its reverse split and after the rally over rescheduling subsided. Tilray foresees continued synergies from international sales through 2026 and its is positioned for entry into US cannabis markets.
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by the president's edict.
Tilray reported Q2 2026 financial results after the bell today. The company reported improvements at the top and bottom of the income statement compared to the same period last year.
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock New Market Opportunity for Tilray Medical Expansion into the U.S. Strong Financial Position with $292 Million in Cash and Marketable Securities 1 and ~$30 Million Net Cash NEW YORK and LONDON and ...
The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical programs and growing international demand. However, investors must still navigate volatility, regulation, and shifting consumer trends.
Tilray stock price has been highly volatile in the past few months as investors focused on Donald Trump's cannabis reclassification efforts and its implications. It surged from $3.59 in June to a high of $23.16 in October.
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is redefining what it means to drink mindfully with a collection that blends craft, creativity, and functionality. From hemp-derived delta-9 THC cocktails to zero-proof spirits and no...
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.